Brief: GT Biopharma Receives Institutional Review Board Approval To Proceed With In Human FDA Phase 1 Clinical Trial
08/04/2019 12:35
April 8 (Reuters) - GT Biopharma Inc GTBP.PK :
* GT BIOPHARMA RECEIVES INSTITUTIONAL REVIEW BOARD APPROVAL
TO
PROCEED WITH IN HUMAN FDA PHASE 1 CLINICAL TRIAL
Source text for Eikon: ID:nCNWn2K1za
Further company coverage: GTBP.PK
((Reuters.Briefs@thomsonreuters.com;))